Alpha Tau Medical Ltd (DRTS)
NASDAQ:DRTS
Total Valuation
Alpha Tau Medical Ltd has a market cap or net worth of $609.03M. The enterprise value is $606.77M.
Market Cap$609.03M
Enterprise Value$606.77M
Share Statistics
Alpha Tau Medical Ltd has 88,009,735 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding88,009,735
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Alpha Tau Medical Ltd’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is -43.50%.
Return on Equity (ROE)-0.55
Return on Assets (ROA)-0.40
Return on Invested Capital (ROIC)-43.50%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee0.00
Profits Per Employee-341.02K
Employee Count125
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Alpha Tau Medical Ltd is ―. Alpha Tau Medical Ltd’s PEG ratio is -0.53.
PE Ratio―
PS Ratio0.00
PB Ratio5.17
Price to Fair Value5.17
Price to FCF-12.18
Price to Operating Cash Flow-22.22
PEG Ratio-0.53
Income Statement
In the last 12 months, Alpha Tau Medical Ltd had revenue of 0.00 and earned -42.63M in profits. Earnings per share was -0.53.
Revenue0.00
Gross Profit-1.23M
Operating Income-42.29M
Pretax Income-42.51M
Net Income-42.63M
EBITDA-41.06M
Earnings Per Share (EPS)-0.53
Cash Flow
In the last 12 months, operating cash flow was -26.68M and capital expenditures -6.08M, giving a free cash flow of -32.76M billion.
Operating Cash Flow-26.68M
Free Cash Flow-32.76M
Free Cash Flow per Share-0.37
Dividends & Yields
Alpha Tau Medical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change182.45%
50-Day Moving Average7.21
200-Day Moving Average4.79
Relative Strength Index (RSI)47.56
Average Volume (3m)280.31K
Important Dates
Alpha Tau Medical Ltd upcoming earnings date is May 25, 2026, Before Open (Confirmed).
Last Earnings DateMar 9, 2026
Next Earnings DateMay 25, 2026
Ex-Dividend Date―
Financial Position
Alpha Tau Medical Ltd as a current ratio of 7.45, with Debt / Equity ratio of 17.80%
Current Ratio7.45
Quick Ratio7.45
Debt to Market Cap0.02
Net Debt to EBITDA0.05
Interest Coverage Ratio-100.93
Taxes
In the past 12 months, Alpha Tau Medical Ltd has paid 121.00K in taxes.
Income Tax121.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Alpha Tau Medical Ltd EV to EBITDA ratio is -9.66, with an EV/FCF ratio of -12.11.
EV to Sales0.00
EV to EBITDA-9.66
EV to Free Cash Flow-12.11
EV to Operating Cash Flow-14.87
Balance Sheet
Alpha Tau Medical Ltd has $76.90M in cash and marketable securities with $13.73M in debt, giving a net cash position of $63.18M billion.
Cash & Marketable Securities$76.90M
Total Debt$13.73M
Net Cash$63.18M
Net Cash Per Share$0.72
Tangible Book Value Per Share$0.96
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Alpha Tau Medical Ltd is $8.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.67
Price Target Upside26.71% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast-22.82%